Company

Navi Therapeutics

Navi Therapeutics researches and develops biological drugs and pharmaceutical materials.

About

Founded in 2024 and based in Shanghai, China, Navi Therapeutics conducts medical research and develops biological drugs and bio-based pharmaceutical materials. Its work includes clinical research, biotechnology process development, and healthcare consulting. In August 2026, it raised Series A funding co-led by Legend Capital and Kangjun Capital, with YuanBio Venture, Trinity Innovation Fund, Oriza Holdings, Tingyu Fund, and other investors participating. The funding will support two ADC candidates, its NaviMIG® and ReviLOAD® platforms, and R&D hiring.

2Funding rounds

5Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in